ProfileGDS4132 / 209235_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 90% 87% 88% 90% 89% 90% 90% 84% 88% 89% 89% 90% 89% 87% 92% 90% 89% 87% 90% 91% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101407.61890
GSM201543Muscle PCOS pioglitazone 121331.63687
GSM201544Muscle PCOS pioglitazone 161418.16488
GSM201545Muscle PCOS pioglitazone 201469.07490
GSM201829Muscle PCOS pioglitazone 231424.3689
GSM201830Muscle PCOS pioglitazon 251430.65190
GSM201831Muscle PCOS pioglitazone 271429.9590
GSM201832Muscle PCOS pioglitazone 31302.93584
GSM201833Muscle PCOS pioglitazone 41378.70388
GSM201834Muscle PCOS pioglitazone 81429.62389
GSM201835Muscle PCOS after pioglitazone 102431.18189
GSM201836Muscle PCOS after pioglitazone 122471.17490
GSM201837Muscle PCOS after pioglitazone 162394.06289
GSM201838Muscle PCOS after pioglitazone 202401.40487
GSM201839Muscle PCOS after pioglitazone 232524.88592
GSM201840Muscle PCOS after pioglitazone 252476.59590
GSM201841Muscle PCOS after pioglitazone 272416.83689
GSM201842Muscle PCOS after pioglitazone 32359.15487
GSM201843Muscle PCOS after pioglitazone 42449.09690
GSM201844Muscle PCOS after pioglitazone 82485.67791